Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer
Daniel Alzate, Angel Yobany Sánchez, Yovana Pacheco, Mario Isaza Ruget, Ramiro Sánchez, Carolina Castillo, Carlos A Parra-López · 2026
Read Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer by Daniel Alzate, Angel Yobany Sánchez, Yovana Pacheco, Mario Isaza Ruget, Ramiro Sánchez, Carolina Castillo, Carlos A Parra-López (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356762.txt.
Description
Daniel Alzate and colleagues validated a whole-exome sequencing pipeline that can diagnose inherited cancer risk in triple-negative breast cancer patients straight from the same test used on their tumors. Their 2026 study built a curated panel of cancer susceptibility genes, proved the pipeline on twenty-five patients with already-confirmed hereditary diagnoses, then applied it to twenty-four triple-negative patients.
One patient in eight in the discovery group carried a harmful inherited variant, landing in three genes that all serve the cell's main DNA repair pathway. The result matters clinically: such diagnoses change a patient's own treatment and trigger testing for relatives. The authors show a single exome test can carry both jobs, tumor profiling and germline answers.
Catalog record
| CREATOR | Daniel Alzate, Angel Yobany Sánchez, Yovana Pacheco, Mario Isaza Ruget, Ramiro Sánchez, Carolina Castillo, Carlos A Parra-López |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33752 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |